Brief: Sedana Medical Q3 EBITDA Loss Widens To SEK 14 Mln

Sedana Medical AB (publ)

04/11/2021 06:19

Nov 4 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL AB (PUBL), THIRD QUARTER REPORT 2021
    * Q3 NET SALES TOTALLED SEK 28 M (21), EQUIVALENT TO AN
INCREASE
OF 32% COMPARED TO Q3 OF 2020
    * Q3 GROSS PROFIT WAS SEK 19 M (13), EQUIVALENT TO A MARGIN
OF 68%
(62).
    * Q3 EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND
AMORTISATION (EBITDA) TOTALLED SEK -14 M (-10), EQUIVALENT TO AN
EBITDA MARGIN OF -50% (-47).
    * Q3 OPERATING INCOME (EBIT) TOTALLED SEK-16 M (-12),
EQUIVALENT
TO AN EBIT MARGIN OF -57% (-55).

Source text for Eikon:  ID:nWkr4BHwXH 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))